Veterinarians Exempt From New Gabapentin Reporting Requirements

Oct 1 | Animal Owners, Companion Animal, Livestock, News

There are no changes for veterinarians regarding Gabapentin reporting at this time.

The Wisconsin Controlled Substances Board has adopted a rule that designates Gabapentin as a monitored prescription drug due to its substantial potential for abuse. The new rule states that effective September 1, 2021, practitioners must review a patient’s prescription drug history prior to prescribing Gabapentin. Dispensers must report Gabapentin dispensing information to the Prescription Drug Monitoring Program (PDMP). Veterinarians are not subject to PDMP reporting requirements and therefore, this rule does not change veterinary practices.